The embolization agents market is projected to reach US$ 4,525.75 million by 2028 from US$ 2,714.82 million in 2021; it is expected to grow at a CAGR of 7.6% from 2021 to 2028.

The growth of the market is attributed to the rising incidence of tumors and aneurysms and growing prevalence of hypertension, obesity, smoking, and alcoholism. However, high costs of embolization agents restrain the embolization agents market growth. Embolization agents are used to apply mechanical occlusion to stop the flow of blood in a blood vessel or vascular area. In interventional radiology, embolization is a common procedure. Embolization procedures are mostly used to treat traumatic injuries. Embolic agents come in a variety of forms, each with its own set of properties and applications. Depending on the duration required for arterial occlusion, embolization agents are classified as temporary or permanent.

In the US, the demand for warts treatment procedures has reduced due to the shift in the focus on COVID-19 treatment. The COVID-19 pandemic has been causing havoc in the global supply chains, consumer markets, and economies. This situation has led to a decline in cardiac procedures carried out in various countries in Asia Pacific. The measures implemented by governments across the world have negatively impacted the embolization agents market growth.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Embolization Agents Market: Strategic Insights

Embolization Agents Market

• 
  CAGR (2021 - 2028)

  7.6%
• Market Size 2021
  US$ 2.71 Billion
• Market Size 2028
  US$ 4.53 Billion

Market Dynamics

GROWTH DRIVERS

• XXXXXXX
• XXXXXXX
• XXXXXXX

FUTURE TRENDS

• XXXXXXX
• XXXXXXX
• XXXXXXX

OPPORTUNITIES

• XXXXXXX
• XXXXXXX
• XXXXXXX

Key Players

• Medtronic
• Terumo Corporation
• Cook Medical LLC
• Boston Scientific Corporation
• Abbott
• Stryker Corporation
• Penumbra, Inc.
• Merit Medical Systems Inc.
• DePuy Synthes

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Product

• Coils
• Plugs
• Beads/Particles
• Detachable Balloons
• Glue
• Sponge
• Liquid Embolics
• Sclerosants
• Precipitating Agents
• Others

Application

• Oncology
• Neurology
• Urology
• Cardiology
• Peripheral Vascular Diseases
• Others

End User

• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers
• Others

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market Insights
Rising Incidence of Tumors and Aneurysms Fuels Embolization Agents Market Growth

According to the National Cancer Institute, in 2020, there were 1,806,590 new cancer cases and 606,520 deaths due to the disease in the US. In 2020, prostate, lung, and colorectal cancers accounted for 43 % of all cancers diagnosed in men. Breast, lung, and colorectal cancers are the three most frequent cancers diagnosed in women. As per the Brain Aneurysm Foundation, Statistics and Facts report, in the US, around 6.5 million people that is 1 in 50 people have an unruptured brain aneurysm. It has also mentioned that 20% of the total people diagnosed with a brain aneurysm have more than one aneurysm. It has further reported that, every year, around 30,000 people in the US suffer from a brain aneurysm rupture and a brain aneurysm rupture takes place every 18 minutes. Further, as per the NHS, every year in the UK, 1 in 12,500 people have a ruptured brain aneurysm in England. Additionally, as per the ‘Unruptured Intracranial Aneurysms Pathogenesis and Individualized Management’ report published in Deutsches Ärzteblatt International in 2020, around 2 million people (adults) in Germany have an unruptured intracranial aneurysm (IA). Embolization agents are used to acutely stop the flow in a blood vessel or vascular territory by the means of mechanical occlusion. Embolizing agents, such as embolic microspheres (beads), are used to restrict the vascular supply to tumors and can be loaded with chemotherapeutic medicines, which elute and diffuse into the tissue. Liquid embolic agents are used to prevent blood supply to aneurysm or tumor. Thus, the increasing prevalence of aneurysms and cancers is creating high demand for embolization agents.

Product-Based Insights

Based on product, the embolization agents market is segmented into coils, beads/particles, plugs, detachable balloons, glue, sponge, liquid embolics, sclerosants, precipitating agents, and others. The beads/particles segment holds the largest share of the market. However, the coil segment is anticipated to register the highest CAGR during 2021–2028. Coil Embolization is a catheter-based procedure that allows precise occlusion of abnormal blood flow in a blood vessel. The increasing number of cardiac surgeries is propelling the market growth of this segment.

Application - Based Insights

Based on application, the embolization agents market is segmented into neurology, oncology, cardiology, peripheral vascular diseases, and others. The oncology segment holds the largest share of the market and is anticipated to register the highest CAGR in the market during the forecast period.

End User-Based Insights

Based on end user, the embolization agents market is segmented into hospitals, ambulatory surgical centers, cardiac centers, and others. The hospitals segment holds the largest market share and is estimated to register the highest CAGR during the forecast period. The market growth for this segment is attributed to the increasing number of hospitals across the world and rapidly growing number of surgical procedures.

Companies operating in the embolization agents market are adopting the product innovations strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market.

Embolization Agents Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Embolization Agents Market – by Product

• Coils
  • Detachable Coils
  • Pushable Coils
• Beads/ Particles
  • Spherical
  • Non-Spherical
• Plugs
• Detachable Balloons
• Glue
• Sponge
• Liquid Embolics
• Sclerosants
• Precipitating Agents
• Others

Embolization Agents Market – by Application

• Oncology
• Neurology
• Urology
• Cardiology
• Peripheral Vascular Diseases
• Others

Embolization Agents Market – by End User

• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers
• Others

Embolization Agents Market– by Geography

• North America

  • US
  • Canada
  • Mexico

• Europe

  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe

• Asia Pacific (APAC)

  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of APAC

• Middle East and Africa (MEA)

  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA

• South and Central America (SCAM)

  • Brazil
  • Argentina
  • Rest of SCAM

Company Profiles

• Medtronic
• Terumo Corporation
• Cook Medical LLC
• Boston Scientific Corporation
• Abbott
• Stryker Corporation
• Penumbra, Inc.
• Merit Medical Systems Inc.
• DePuy Synthes
• KANEKA CORPORATION